- Home
- NPWR vs SGMO Comparison
NPWR vs SGMO Comparison
Compare NPWR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- SGMO
- Stock Information
- Founded
- NPWR 2010
- SGMO 1995
- Country
- NPWR United States
- SGMO United States
- Employees
- NPWR N/A
- SGMO N/A
- Industry
- NPWR Industrial Machinery/Components
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPWR Energy
- SGMO Health Care
- Exchange
- NPWR Nasdaq
- SGMO Nasdaq
- Market Cap
- NPWR 148.7M
- SGMO 122.8M
- IPO Year
- NPWR N/A
- SGMO 2000
- Fundamental
- Price
- NPWR $2.16
- SGMO $0.46
- Analyst Decision
- NPWR Buy
- SGMO Buy
- Analyst Count
- NPWR 2
- SGMO 6
- Target Price
- NPWR $4.00
- SGMO $4.50
- AVG Volume (30 Days)
- NPWR 2.7M
- SGMO 4.0M
- Earning Date
- NPWR 08-11-2025
- SGMO 08-05-2025
- Dividend Yield
- NPWR N/A
- SGMO N/A
- EPS Growth
- NPWR N/A
- SGMO N/A
- EPS
- NPWR N/A
- SGMO N/A
- Revenue
- NPWR $250,000.00
- SGMO $63,756,000.00
- Revenue This Year
- NPWR $308.00
- SGMO N/A
- Revenue Next Year
- NPWR $1,811.08
- SGMO N/A
- P/E Ratio
- NPWR N/A
- SGMO N/A
- Revenue Growth
- NPWR 100.00
- SGMO 239.92
- 52 Week Low
- NPWR $1.48
- SGMO $0.30
- 52 Week High
- NPWR $14.28
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- NPWR 47.55
- SGMO 38.27
- Support Level
- NPWR $2.30
- SGMO $0.49
- Resistance Level
- NPWR $2.63
- SGMO $0.51
- Average True Range (ATR)
- NPWR 0.38
- SGMO 0.04
- MACD
- NPWR -0.02
- SGMO 0.01
- Stochastic Oscillator
- NPWR 22.48
- SGMO 6.25
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.